Below is a timeline of opioid settlements that have been reached since January, reported by Becker’s Hospital Review. The timeline doesn’t include opioid settlements that are still pending or have been agreed to in principle, including a proposed settlement from Purdue Pharma and a global settlement from several drug distributors.

March 26: Purdue Pharma agrees to pay $270 million to Oklahoma to resolve claims it fueled the opioid crisis in the state. 

June 6: Insys Therapeutics agrees to pay $225 million to settle claims it illegally marketed an addictive fentanyl painkiller used to treat pain in cancer patients.

July 11: Reckitt Benckiser Group, a U.K. consumer goods company, agrees to pay $1.4 billion to settle claims it profited by deceiving healthcare providers about the safety of its opioid-addiction treatment, Suboxone.

Read the source article.